- Conditions
- Edematous Fibrosclerotic Panniculopathy (EFP)
- Interventions
- Collagenase Clostridium Histolyticum, Placebo
- Biological
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 10
- States / cities
- San Diego, California • Santa Monica, California • Coral Gables, Florida + 7 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–20
of 20
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Cellulite
- Interventions
- CBL-514 injection
- Drug
- Lead sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Industry
- Eligibility
- 18 Years to 64 Years · Female only
- Enrollment
- 23 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 5
- States / cities
- Encinitas, California • Encino, California • San Diego, California + 2 more
- Conditions
- Edematous Fibrosclerotic Panniculopathy (EFP), Cellulite
- Interventions
- CCH-aaes, Compression, Cold Packs, Arnica Gel, INhance®, PDL
- Drug · Other
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 48 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2021
- U.S. locations
- 8
- States / cities
- Scottsdale, Arizona • Sacramento, California • San Diego, California + 5 more
- Conditions
- Edematous Fibrosclerotic Panniculopathy
- Interventions
- Previously Treated with EN3835
- Biological
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019
- U.S. locations
- 5
- States / cities
- Clearwater, Florida • Coral Gables, Florida • Washington, Missouri + 2 more
- Conditions
- Edematous Fibrosclerotic Panniculopathy
- Interventions
- Previously Treated with EN3835
- Drug
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020
- U.S. locations
- 4
- States / cities
- Clearwater, Florida • Coral Gables, Florida • Washington, Missouri + 1 more
- Conditions
- Edematous Fibrosclerotic Panniculopathy (Cellulite)
- Interventions
- EN3835, Placebo
- Biological
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 423 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018
- U.S. locations
- 26
- States / cities
- Scottsdale, Arizona • Encinitas, California • Long Beach, California + 21 more
- Conditions
- Edematous Skin
- Interventions
- collagenase clostridium histolyticum (CCH)
- Drug
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 64 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2019
- U.S. locations
- 5
- States / cities
- Coral Gables, Florida • Miami, Florida • New York, New York
- Conditions
- Edematous Fibrosclerotic Panniculopathy, Cellulite
- Interventions
- CCH-aaes, Antifibrinolytic Agent
- Drug
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years to 60 Years · Female only
- Enrollment
- 91 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 13
- States / cities
- Scottsdale, Arizona • Beverly Hills, California • Encinitas, California + 10 more
- Conditions
- Edematous Fibrosclerotic Panniculopathy, Cellulite
- Interventions
- COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, Placebo Comparator
- Biological
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 375 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016
- U.S. locations
- 16
- States / cities
- Beverly Hills, California • Murrieta, California • Oceanside, California + 12 more
- Conditions
- Cellulite, Edematous Fibrosclerotic Panniculopathy (EFP)
- Interventions
- EN3835
- Drug
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 7 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Coral Gables, Florida
- Conditions
- Cellulite
- Interventions
- 40 mg CBL-514, 60 mg CBL-514, 80 mg CBL-514
- Drug
- Lead sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Industry
- Eligibility
- 18 Years to 64 Years · Female only
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023
- U.S. locations
- 2
- States / cities
- Encino, California • New York, New York
- Conditions
- Edematous Fibrosclerotic Panniculopathy (EFP), Cellulite
- Interventions
- EN3835
- Drug
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years to 60 Years · Female only
- Enrollment
- 153 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2021
- U.S. locations
- 11
- States / cities
- Encino, California • San Diego, California • Solana Beach, California + 8 more
- Conditions
- Cellulite, Laxity; Skin, Edematous Fibrosclerotic Panniculopathy
- Interventions
- Not listed
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years to 55 Years · Female only
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022
- U.S. locations
- 3
- States / cities
- Coral Gables, Florida • Metairie, Louisiana • New York, New York
- Conditions
- Edematous Fibrosclerotic Panniculopathy
- Interventions
- CCH (collagenase clostridium histolyticum)
- Biological
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 12 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Edematous Fibrosclerotic Panniculopathy, Cellulite
- Interventions
- CCH-aaes, Observation
- Biological · Other
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 483 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 42
- States / cities
- Glendale, Arizona • Scottsdale, Arizona • North Little Rock, Arkansas + 33 more
- Conditions
- Edematous Fibrosclerotic Panniculopathy (Cellulite)
- Interventions
- EN3835, Placebo
- Biological
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 422 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018
- U.S. locations
- 25
- States / cities
- Glendale, Arizona • North Little Rock, Arkansas • Beverly Hills, California + 22 more
- Conditions
- Edematous Fibrosclerotic Panniculopathy, Cellulite
- Interventions
- Collagenase Clostridium Histolyticum
- Biological
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 158 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 11
- States / cities
- Scottsdale, Arizona • Huntington Beach, California • San Diego, California + 8 more
- Conditions
- Edematous Fibrosclerotic Panniculopathy, Cellulite
- Interventions
- Collagenase Clostridium Histolyticum
- Biological
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 259 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 15
- States / cities
- Beverly Hills, California • Murrieta, California • Oceanside, California + 11 more
- Conditions
- Edematous Fibrosclerotic Panniculopathy, Cellulite
- Interventions
- COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
- Biological
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 21 Years to 60 Years · Female only
- Enrollment
- 99 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Edematous Fibrosclerotic Panniculopathy, Cellulite, Laxity; Skin
- Interventions
- collagenase clostridium histolyticum
- Drug
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years to 55 Years · Female only
- Enrollment
- 35 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2021
- U.S. locations
- 3
- States / cities
- Coral Gables, Florida • Metairie, Louisiana • New York, New York